No staff COVID-19 diagnoses after plan at Chinese cancer centerApril 2, 2020COVID-19 UpdatesBreast CancerGenitourinary CancerLung CancerMelanomaOncology
Maintaining cancer care in the face of COVID-19April 1, 2020COVID-19 UpdatesGenitourinary CancerLung CancerMultiple MyelomaMelanomaInfectious DiseasesOncology
Blood test might detect multiple cancer types, study suggestsMarch 31, 2020OncologyMixed TopicsLung CancerGenitourinary Cancer
Week-old COVID-19 urology guidelines already outdatedMarch 25, 2020COVID-19 UpdatesGenitourinary Cancer
Cancer care and COVID-19 in Seattle, the first U.S. epicenterMarch 23, 2020COVID-19 UpdatesBreast CancerGenitourinary CancerLung CancerMelanomaOncology
How is oncology adapting to COVID-19?March 23, 2020COVID-19 UpdatesBreast CancerGenitourinary CancerLung CancerMelanoma
Disruptions in cancer care in the era of COVID-19March 20, 2020COVID-19 UpdatesBreast CancerGenitourinary CancerLung CancerMelanomaOncology
Best definition of malnutrition varies by cancer typeMarch 6, 2020Genitourinary CancerLung CancerMixed TopicsOncology
Combined biopsy method improves diagnostic accuracy in prostate cancerMarch 4, 2020Genitourinary CancerProstate CancerOncology
Gene therapy appears effective in bladder cancer patients with few optionsFebruary 26, 2020Genitourinary CancerOncology
Lenvatinib/pembrolizumab has good activity in advanced RCC, other solid tumorsJanuary 31, 2020Immuno-oncologyGenitourinary CancerMelanomaLung CancerOncology
Atezolizumab/bevacizumab may offer benefit to patients with RCCNovember 25, 2019Genitourinary CancerImmuno-oncologyOncology
Combo shows promise for checkpoint inhibitor-refractory urothelial carcinomaNovember 12, 2019Genitourinary CancerImmuno-oncologyOncology
